Quantcast

Latest MorphoSys Stories

2014-03-13 08:28:48

MONROVIA, Calif., March 13, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to...

2014-03-07 08:25:11

LONDON and BOSTON, March 7, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that its Chief Executive Officer, Malcolm Weir, will participate in a panel discussion entitled, "Addressing cognitive deficits across CNS disorders: Potential to improve overall functional outcomes and QoL" (2:45pm-3:45pm CET on 10 March) at BIO-Europe Spring 2014 [http://www.ebdgroup.com/bes/index.php ], which takes place in...

2014-03-05 08:29:20

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein and Glycoengineered Antibodies Market" [http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from...

2014-01-23 04:21:26

LONDON and BOSTON, January 23, 2014 /PRNewswire/ -- Stabilised GPCR (StaR(R)) Proteins Delivered For All Nominated Targets Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, has successfully completed the research phase of its antibody drug discovery collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. In achieving this milestone, Heptares has delivered StaR(R) proteins...

2014-01-08 04:21:15

WELWYN GARDEN CITY, England and BOSTON, January 8, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery and development company, notes that its President, Dan Grau, will moderate a panel discussion entitled "Global Entrepreneurs: Biotech Building Beyond Borders" (1:30-2:00pm Eastern time on 11 January) at the Boston Biotech East/West CEO Conference [http://bbbiotechconference.com/conference-agenda.php?id=14 ], which takes place at the Four Seasons...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin